1. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physician. Ann Intern Med. 2018.DOI: 10.7326/M17-0939. 2. 中国2型糖尿病防治指南(2017年版),中华糖尿病杂志,2018...
The article discusses how to make the best of the HbA 1c targets for diabetes. Here is summarised a strategy for achieving HbA 1c targets in patients with type 2 diabetes. While the modern management of type 2 diabetes can often focus on drug treatments, diet and exercise also play a ...
1. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physician. Ann Intern Med. 2018.DOI: 10.7326/M17-0939. ...
[3] Qaseeen A,Wilt TJ,Kansagara D,et al.Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpreganant adults with type 2 diabetes mellitus:A guidance statement update from the American College of Physicians[J].Ann Intern Med,2018,168(8):569-576.doi:10.7326/M17-0939...
1. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physician. Ann Intern Med. 2018.DOI: 10.7326/M17-0939.
[3] Qaseeen A,Wilt TJ,Kansagara D,et al.Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpreganant adults with type 2 diabetes mellitus:A guidance statement update from the American College of Physicians[J].Ann Intern Med,2018,168(8):569-576.doi:10.7326/M17-0939...
[9]QaseemA, WiltTJ, KansagaraD, et al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American College of Physicians[J]. ...
1. Qaseem A, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med. 2018;doi:10.7326/M17-0939. ...
2例患者均以16剂量单位德谷胰岛素利拉鲁肽注射液起始,经调整最终HbA1c均达到7%以下,空腹及餐后血糖控制良好,用药期间无低血糖发生、无体重额外增加、无胃肠道反应出现,二者依从性好,耐受性强,整体上降糖效果良好。 徳谷胰岛素利拉鲁肽注射液是一种由德谷胰岛素和利拉鲁肽组成的复方制剂,两种成分在皮下注射后保持...
(2)The National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management - NICE guideline NG28 作者使用指南推荐的目标水平确定7个危险因素是否在目标范围内,包括: (1)当前不吸烟 (2)达到目标体力活动(每周≥150分钟的中等强度活动或每周≥75分钟的剧烈活动或等效组合) ...